Plandai Biotechnology (Plandai Biotechnology) EV-to-EBIT : -0.18 (As of May. 21, 2024)

Plandai Biotechnology EV-to-EBIT Chart

Plandai Biotechnology Annual Data
	Trend	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-EBIT		Get a 7-Day Free Trial					-3.85	-5.52	-6.00	1.53	-0.17

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial											-3.85	-5.52	-6.00	1.53	-0.17

Competitive Comparison of Plandai Biotechnology's EV-to-EBIT

For the Shell Companies subindustry, Plandai Biotechnology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's EV-to-EBIT falls into.

Plandai Biotechnology EV-to-EBIT Calculation

Plandai Biotechnology's EV-to-EBIT for today is calculated as:

Plandai Biotechnology's current Enterprise Value is $3.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology  (OTCPK:PLPL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Plandai Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Plandai Biotechnology's Enterprise Value for the quarter that ended in Jun. 2023 was $3.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plandai Biotechnology's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description